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An Essential Cytoskeletal Linker Protein
Connecting Actin Microfilaments
to Intermediate Filaments
Yanmin Yang,* James Dowling,* Qian-Chun Yu,* two forms of BPAG1, one expressed in epidermis and
one in neurons (Guo et al., 1995). Additional evidencePanos Kouklis,* Don W. Cleveland,† and Elaine Fuchs*
*Howard Hughes Medical Institute came from Brown et al. (1995a), who cloned the site of
a 70 kb insertion/45 kb deletion from an hsp70–lacZDepartment of Molecular Genetics and Cell Biology
The University of Chicago transgene random integration event that occurred within
several hundred kilobases of the BPAG1e locus onChicago, Illinois 60637
†Ludwig Institute for Cancer Research mouse chromosome 1, creating a dt/dt phenotype (Ko-
thary et al., 1988). These researchers isolated a partialDepartments of Medicine and Neuroscience
University of California, San Diego brain cDNA that encoded 214 amino-terminal residues
sharing similarity to the actin-binding domain (ABD) ofLa Jolla, California 92093
b-spectrin and a-actinin. Whether this is a functional
actin-binding site is unclear. Moreover, other research-
ers have previously isolated a partial cDNA encodingSummary
yet another form of BPAG1 protein (BPAG1t) that differs
in its carboxy-terminal sequences (Hopkinson andTypified by rapid degeneration of sensory neurons,
Jones, 1994).dystonia musculorum mice have a defective BPAG1
We were interested in the possible cytoskeletal inter-gene, known to be expressed in epidermis. We report
actions of BPAG1n as a means of understanding howa neuronal splice form, BPAG1n, which localizes to
the absence of BPAG1n can cause dramatic neurologicsensory axons. Both isoforms have a coiled-coil rod,
degeneration. As reported for dt/dt mice (Sotelo andfollowed by a carboxy domain that associates with
Guenet, 1988), axons degenerate within the peripheralintermediate filaments. However, the amino terminus
nervous system of 4-week-old BPAG1 knockout miceof BPAG1n differs from BPAG1e in that it contains a
(Guo et al., 1995). Severely affected are the large primaryfunctional actin-binding domain. In transfected cells,
sensory axons, while more modest degeneration is seenBPAG1n coaligns neurofilaments and microfilaments,
in second order sensory neurons and in a few motorestablishing this as a cytoskeletal protein intercon-
neurons. Studies on mouse chimeras composed of dt/necting actin and intermediate filament cytoskeletons.
dt and wild-type cells indicate that the defect is intrinsicIn BPAG1 null mice, axonal architecture is markedly
(although not necessarily exclusively) to sensory neu-perturbed, consistent with a failure to tether neurofila-
rons (Campbell and Peterson, 1992).ments to the actin cytoskeleton and underscoring the
The extent to which BPAG1n shares sequences withphysiological relevance of this protein.
BPAG1e or BPAG1t is key to deciphering why it is an
essential protein. The carboxy-terminal portion ofIntroduction
BPAG1e, missing in BPAG1t, is predicted to associate
with keratin IFs. If BPAG1n contains this putative IFThe 230 kDa epidermal form of bullous pemphigoid anti-
domain of BPAG1e, it might have the extraordinary ca-gen 1 (BPAG1e), first identified with antisera from pa-
pacity to bind simultaneously to both actin microfila-tients with the autoimmune disorder, bullous pemphi-
ments (MFs) and IFs. On the other hand, if BPAG1ngoid (BP; Stanley, 1993), belongs to a small group of
is missing this domain, it might differ completely fromlarge coiled-coil proteins that includes desmoplakin and
BPAG1e in its cytoskeletal associations. In this report,plectin (Green et al., 1992). Both desmoplakin and plec-
we determine the complete structure of BPAG1n proteintin can associate with intermediate filaments (IFs)
and show that it has functional actin- and neurofilament(Foisner et al., 1991; Stappenbeck and Green, 1992;
(NF)-binding sites at opposite ends of its coiled-coilKouklis et al., 1994). While plectin decorates IF networks
rod. Accumulating along the length of sensory axons,and is expressed ubiquitously, desmoplakin connects
BPAG1n represents a novel class of cytoskeletal proteinIFs to desmosomes in muscle and stratified epithelia.
that serves a key in vivo role of linking actin and IFSimilar studies have not yet been conducted with
arrays. Our findings provide insights into the possibleBPAG1e, although this protein localizes to the intracellu-
relation of recessive BPAG1 mutations to severe humanlar portion of the hemidesmosomal plaque, in a region
neurodegenerative disorders.where keratin filaments associate with the plaque (Stan-
ley, 1993). Recent knockout studies revealed that basal
epidermalcells lackingBPAG1e have hemidesmosomes Results
with seemingly normal structure, but with severed con-
nections to thekeratin IF cytoskeleton (Guo et al., 1995). The Brain Form of BPAG1 Contains the Complete
Coding Sequence of BPAG1e, minus Exon 1Surprisingly, ablation of the BPAG1 gene in mice (Guo
et al., 1995) produced gross, rapid sensory neuron de- To identify the form of BPAG1 expressed in brain, we
screened a human fetal brain cDNA library with a cDNAgeneration identical to dystonia musculorum (dt/dt), a
well-known autosomal recessive mouse mutant (Du- to exons 2–5 of the epidermal form of BPAG1. Five
different cDNAs were identified. Rapid amplification ofchen, 1976). While allelic with our BPAG1 null mice,
only one of two previously identified dt/dt mouse strains cDNA ends (RACE) completed the encoded amino-ter-
minal segment. Sequencing revealed the existence oflacked BPAG1e, leading us to predict the existence of
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Figure 1. Elucidating the Complete Structure
of BPAG1n mRNA and Protein
(A) PCR analysis of mouse and human skin
and brain BPAG1 mRNAs. Total RNAs were
isolated from skin (S) and brain (B) tissues
of human or 14-day-old wild-type (wt) and
BPAG1 null (2/2) mice. Oligonucleotide
primers were used to PCR amplify mouse and
human BPAG1 sequences, and DNA frag-
ments were resolved by agarose gel electro-
phoresis (2% left gel; 1% right gel) and visual-
ized by ethidium bromide staining. Shown are
mouse data. Fragments encompassed are as
follows: lanes 1 and 2, exons 1 and 2 of
BPAG1e; lanes 3 and 4, exon 2 of BPAG1e;
lanes 5 and 6, b-actin cDNA (control); lanes
7 and 8, exons 15–21, which comprise the
coiled-coil rod of BPAG1e; and lanes 9–11,
the nonhelical tail of BPAG1e. Migration of
DNA standards are indicated at left and right.
(B) Northern blot analysis of mouse skin and
brain BPAG1 mRNAs. Poly(A)1 RNAs (2 mg)
were resolved by electrophoresis through
formaldehyde–agarose gels (0.6%). RNAs
were transferred by blotting to nitrocellulose,
and blots were hybridized with 32P-labeled
cDNA probes against (top) a 680 bp mouse
BPAG1n cDNA corresponding to the 59 cod-
ing segment unique to BPAG1n, (middle) a
1.2 kb mouse BPAG1e cDNA spanning parts
of exons 21 and 22 (39 coding segment), or
(bottom) a 1 kb mouse glyceraldehyde phos-
phate dehydrogenase (GAPDH) cDNA (con-
trol). Migration of RNA standards is indicated
at left.
(C) Immunoblot analysis of skin (S), brain (B), and spinal cord (SC) proteins isolated from (2/2) and wild-type mice. Protein extracts in 20 mM
Tris–HCl (pH 7.5), 1% Triton X-100, 0.1% SDS, 5 mM EDTA were resolved by electrophoresis through 6% SDS–polyacrylamide gels and then
transferred to nitrocellulose by electroblotting. Blots were stained with Ponceau red (data not shown) to examine relative loadings and then
subjected to immunoblot analysis with (left) m5E monoclonal antibody against a BPAG1 tail epitope (1:500 dilution) and (right) anti-BPAG1n
(1:1000 dilution). Horseradish peroxidase secondary antibodies and chemiluminescence were used to develop the signal. Migration of muscle
myosin (200 kDa) control is shown. Note single BPAG1n band, despite the existence of two isoforms based on cDNA analysis.
(D) Diagram of four human BPAG1 isoforms. Shown are protein structures of two BPAG1n isoforms, determined from amino acid 1 through
exon 2 (II) of BPAG1e by Brown et al. (1995a, 1995b) and assessed in their entirety here. Numbers at top represent amino acids of the BPAG1n1
sequence. Shown also is the complete protein structure of human BPAG1e, with a unique exon 1 (I) determined by Tamai et al. (1993), and
the hypothesized structure of the 280 kDa human pancreatic BPAG1t, partially cloned as a putative tailless BPAG1 (Hopkinson and Jones,
1994).
two transcripts that differ in their 59 sequence, encoding sets encompassing BPAG1e, including the z625 amino
acid residue coiled-coil “rod” (exons 16–20) and the 768a divergent initial 31 (for BPAG1n1) and 215 (for
BPAG1n2) amino acids, followed by 352 shared residues residue “tail” (exons 21 and 22) (Tamai et al., 1993). In
all cases, PCR bands were generated from skin andprior to amino acid residue 55 of BPAG1e. These two
brain forms matched with recently published 59 seg- brain RNAs; these bands were not present in RNAs from
BPAG1 (2/2) knockout mice. Sequence analyses of thements of human brain BPAG1n cDNA (Brown et al.,
1995b). To identify the more carboxy-terminal structures isolated cDNA clones showed that the encoded 1103
amino acid “head” (exons 2–15) was present in bothof the two brain BPAG1s, reverse transcriptase–poly-
merasechain reaction (RT–PCR) of isolated mouse brain BPAG1n1 and BPAG1n2. Sequence analyses of the PCR
fragments confirmed that the remaining exons ofRNA was used to amplify the coding segments of
BPAG1n1 and BPAG1n2 mRNAs (Figure 1A). Oligonu- BPAG1e (exons 15–22) are present in brain RNAs.
Northern blot analysis demonstrated the existence ofcleotide primers spanning exons 1 and 2 of BPAG1e
amplified a band only in skinand not in brain. In contrast, a 12 kb brain BPAG1n RNA(s) hybridizing to radiolabeled
probes to the 59 and 39 sequences common to bothprimer pairs within exon 2 generated a band in both skin
and brain. Similar data were obtained with human RNAs BPAG1n isoforms (Figure 1B). This RNA was not de-
tected in whole skin preparations or in brain tissue from(data not shown). Collectively, these results verified the
existence of human and mouse RNAs encoding the BPAG1 knockout mice (2/2). Thus, the 12 kb BPAG1n
mRNA is not appreciably expressed in skin, in contrastcloned BPAG1n cDNAs, and revealed that the BPAG1e
form is not expressed in brain. with prior predictions based on detection of a BPAG1-
related RNA in a cultured epithelial line (Brown et al.,To determine the remainder of the BPAG1n1 and
BPAG1n2 sequences, we used oligonucleotide primer 1995a).
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The z280 kDa BPAG1n Protein Is Present
in Brain and Spinal Cord
To verify the existence of BPAG1n protein, immunoblots
of extracts from skin, brain, and spinal cord were probed
with a monoclonal antibody (E5a) made from a BP pa-
tient autoantisera and recognizing an epitope in the
BPAG1e tail segment (Sugi et al., 1989). In addition to
binding to the 230 kDa BPAG1e band in skin, this anti-
body detected a 280 kDa band in brain and spinal cord
(Figure 1C). That this band corresponds to BPAG1n was
confirmed by probing a second blot with a rabbit antise-
rum prepared against theputative ABD of BPAG1n fused
to glutathione S-transferase (GST). We conclude that a
single protein contains the carboxy-terminal sequence
common to skinand brain BPAG1 isoforms as well as the
amino-terminal sequence encoded by the brain cDNAs.
The size of the BPAG1n band corresponded to that
predicted for BPAG1n1, although the antibody should
have detected both isoforms with equal affinity. A minor
band of z250 kDa was also detected (see lane 1 of
Figure 1C); its identity remains unknown.
Figure 1D summarizes the structure of BPAG1n1 and
BPAG1n2 relative to other BPAG1 forms. Since dystonia
musculorum does not appear to be a bona fide model
of human dystonia, and since both brain and skin
BPAG1s are antigenic determinants of BP autoantisera,
we have kept thenomenclature first set for the epidermal
form, and henceforth we refer to the 280 kDa band de-
tected in Figure 1C as BPAG1n.
BPAG1n Is Expressed Primarily in Sensory Neurons
To examinethe role of BPAG1n in the central and periph-
eral nervous system, we first used in situ hybridization
to determine where BPAG1n mRNAs are expressed. As
shown in Figure 2A and viewed at higher magnification
in Figure 2B, the perikarya of the dorsal root ganglia
(DRG) neurons of neonatal mice hybridized with dide-
goxygenin-labeled, BPAG1n-specific cRNA. When com-
pared with a trkC probe, which labeled the 1a afferent
subset of primary sensory neurons (Figure 2C), it was
clear that BPAG1n mRNAs were expressed more widely
within the sensory neuron population (Figure 2B). The
smaller satellite cells within the DRG did not appear to Figure 2. In Situ Hybridizations Reveal Abundant and Specific
label with the probe (arrows in inset to Figure 2B), nor Expression of BPAG1n RNA in All Primary Sensory Neurons of
the DRGdid cells of the BPAG1 knockout mice (data not shown).
In situ hybridizations were performed on frozen transverse sectionsMoreover, in contrast with the BPAG1n cRNA labeling
from postnatal day 1 mice according to Yang et al. (1996). Hybridiza-in the DRG, neither the spinal cord, sensory roots, nor
tions using didegoxygenin (DIG) cRNAs were performed for 16 hrperipheral nerves gave labeling above background. Col-
at 728C, followed by stringent washes for 3 hr at 728C in 0.23 SCC.
lectively, our data demonstrated, first, the existence of Colorimetric detection was by an alkaline phosphatase–conjugated
BPAG1n RNAs in most if not all postnatal DRG neurons goat anti-DIG antibody (1:5000 dilution; Boehringer Mannheim).
(A) Cross section of spinal cord hybridized with probe specific forand, second, little if any labeling in postnatal motor neu-
a 543 bp (nucleotides 699–1242) fragment of mouse BPAG1n2.rons, satellite cells, oligodendrocytes, or Schwann cells.
(B) Higher magnification of region in (A), showing DRG-specific hy-To determine the location of BPAG1n within sensory
bridization; inset shows labeling of larger sensory cell bodies, but
neurons, anti-BPAG1n antiserum was used for immuno- not smaller satellite cells (similar to Schwann cells; arrows). SR,
gold immunohistochemistry on postnatal central and senory root.
peripheral nervous system tissue sections (Figure 3). As (C) DRG labeled with DIG probe specific for a 433 bp fragment of
the trkC receptor cDNA (Minichiello et al., 1995), present in a subsetjudged by antibody labeling, BPAG1n protein did not
of sensory neurons within the DRG.appear to remain in DRG cell bodies where its mRNA
Bar in (A) represents 150 mm in (A); 80 mm in (B) and (C); and 15
was produced; rather anti-BPAG1n staining was promi-
mm in the inset.
nent in axonal rootlets (Figures 3A and 3B). Relative to
the unlabeled spinal cord of the BPAG1 null mouse
Cell
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Figure 3. Immunohistochemistry Reveals of
BPAG1n in the Axons and Preterminal
Branches of the Sensory Neurons of the Pe-
ripheral and Central Nervous System
Frozen tissue sections (20 mm)of brain, spinal
cord, and skin were taken from wild-type (A,
B, and D–I) and BPAG1 null (C) mice at 12
days after birth. Sections were treated with
methanol (2208C) for 10 min, washed three
times with phosphate-buffered saline (PBS),
preblocked with 1% BSA, 0.1% Triton X-100,
and 1% gelatin in PBS, and then exposed to
anti-BPAG1n (1:100 dilution) at room temper-
ature overnight. After washing three times
with PBS for 10 min each,sections were incu-
bated with secondary antibody (1:50 dilution)
conjugated with immunogold for 30 min, and
then washed andmounted. Sections were ex-
amined using a Zeiss Axiophot immunofluo-
rescence microscope. All signals shown were
specific for BPAG1n and were not seen in
BPAG1 (2/2) sections.
(A) Sagittal segment of spinal cord, revealing
reduced staining in DRG perikarya relative to
axonal rootlets. DR, dorsal root.
(B) A closer view of a DRG.
(C) Cross section of (2/2) spinal cord (SC).
(D) Cross section of spinalcord to show stain-
ing in dorsal column (DC).
(E and F) Sagittal views to show labeling of
nerve fibers in dorsal column.
(G) Cross section of sciatic nerve (arrows),
revealing staining in region closest to arrows.
(H) Muscle spindle (MS).
(I) Sensory nerve endings in skin; note label-
ing of termini (arrows).
Bar in (A) represents 16 mm in (A), (E), (G),
and (I); 8 mm in (B) and (F); 60 mm in (C) and
(D); and 4 mm in (H).
(Figure 3C), axons within the dorsal column of wild-type 2, present in both BPAG1e and BPAG1n. Axons in the
spinocerebellar tract also stained positive for BPAG1nmice were strongly positive (Figure 3D).Sagittal sections
of dorsal column revealed staining along its length (Fig- (data not shown). These secondary nerve fibers serve
as important sensory relays to the brain, where theyures 3E and 3F). Closer inspection of this region showed
that the staining was specific for sensory nerve fibers deliver signals that originate from primary sensory fibers
coming from muscle. Thus, expression of BPAG1n was(Figure 3F).
In contrast with the immunoreaction in the dorsal col- not restricted to primary sensory neurons, but extended
to some secondary sensory neurons.umn, the ventral portion of the spinal cord displayed
little or no detectable staining with anti-BPAG1n (Figure Our findings are consistent with the pathology of the
BPAG1 knockout and dt/dt mice, but they differ mark-3D), a finding expected from the absence of BPAG1n
RNAs in similar sections (Figure 2A). These data argue edly from the predictionsof BPAG1n expression inferred
from following expression of a hsp70–lacZ transgenethat the majority of motor dysfunction in the BPAG1
knockout mice is secondary. Consistent with this notion integrated into the BPAG1 locus in a dt/dt mouse mutant
(Kothary et al., 1988).is that the sciatic nerve, which contains a mixture of
motor and sensory axons, displayed some axons that
stained with anti-BPAG1n and others that did not (Fig- The BPAG1 Tail Associates with IF Networks
The carboxy-terminal tail of desmoplakin associatesure 3G).
Anti-BPAG1n staining was also detected in muscle with epidermal keratin networks in vivo (Kouklis et al.,
1994). Given 40%amino acid sequence identity betweenspindles, the stretch receptors in skeletal muscle that
are innervated by sensory nerve terminals from the DRG an z300 residue portion of the tails of desmoplakin and
BPAG1 (Green et al., 1992), and given the finding thatas well as motor neurons (Figure 3H). BPAG1n antibody
staining was also found in the sensory nerve termini ablation of BPAG1e severs the connection between ker-
atin IFs and hemidesmosomes (Guo et al., 1995), wewithin skin (Figure 3I). The epidermal labeling was likely
due to the ability of the antibody to detect BPAG1 exon tested whether the BPAG1 tail might have the capacity
BPAG1n: An Essential Cytoskeletal Linker Protein
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Figure 4. The Carboxy-Terminal Tail of BPAG1 Decorates IF Networks, and the Amino-Terminal Domain of BPAG1n Colocalizes with Actin
Networks
SCC-13 human epidermal keratinocytes (keratin IF positive [A–C]) and SW13 human adrenal carcinoma cells (IF negative [D–K]) were transiently
transfected with pFG-BPAG1tail alone (A–D), pBPabd-FG alone (H–J), or with a 1:1:1 molar ratio of murine sarcoma virus–NF-L expression
vector (MSV-NFL), MSV-NFH, and either pFG-BPAG1tail (E–G) or pBPabd-FG (K). After 28 (SCC-13) or 36 hr (SW13), cells were fixed and
subjected to double immunofluorescence as described previously (Albers and Fuchs, 1987). Transfected cells were stained with the following:
(A), (D), (E), and (I), mouse anti-FLAG M2 monoclonal antibody (10 mg/ml; IBI-Kodak); (B), anti-K5, against an epidermal keratin; (F), affinity-
purified rabbit anti-NF-H polyclonal antisera (1:300); (C), guinea pig anti-K5 (1:100; Lersch et al., 1989)/anti-FLAG; (G) and (K), anti-NF-H/anti-
FLAG; (H), mouse monoclonal b-actin antibody (1:100; Sigma); (J), anti-actin/anti-FLAG. Appropriate FITC- and Texas red–conjugated secondary
antibodies were used to detect bound antibodies. Bar represents 16 mm for (A)–(G) and (K) and 10 mm for (H)–(J).
to associate with IF networks. The entire 768 residue posttransfection, implying that the BPAG1 tail is stabi-
lized by binding to an IF array.tail of human BPAG1n/e, tagged at its amino terminus
with a small epitope (FLAG), was expressed transiently To verify that the association between BPAG1 tail
and NFs was specific, transfections were repeated inin SCC-13 keratinocytes. The BPAG1 tail decorated the
epidermal IF network (Figures 4A–4C), which in the ma- monkey kidney epithelial (COS) cells that harbor the
simian virus 40 (SV40) T antigen, resulting in amplifica-jority of transfected cells was unaffected by the
transgene product. tion of the transfected plasmids. Following transfection,
cell extracts were prepared and first subjected to immu-When expressed in the SW13 cell line lacking cyto-
plasmic IFs, the BPAG1 tail accumulated diffusely in the noblot analyses to verify that the proteins were stably
expressed and of the expected size. As shown in Figurecytoplasm, devoid of a filamentous appearance (Figure
4D). An immunofluorescence signal could only be seen 5A, the z80 kDa BPAG1 tail protein accumulated, as
did NF-L (z70 kDa), NF-H (z200 kDa), and full-lengthat early timepoints after transfection (e.g., 24 hr), sug-
gesting that the protein is unstable in this cell line. In BPAG1n (280 kDa).
To examine the specificity of the association betweencontrast, when an extensive array of NFs was produced
in vivo by cotransfection with a 1:1 ratio of NF-L (light the BPAG1 tail segment and NFs, we transfected COS
cells with the BPAG1 tail or NF-H constructs (or both)chain) and NF-H (heavy chain) expression vectors (Lee
et al., 1993), the BPAG1 tail decorated the cytoskeletal and incubated the cells in the presence of medium con-
taining [35S]methionine. After 28 hr, extracts were sub-array of NFs (Figures 4E–4G). In this case, the anti-FLAG
immunofluorescence signal was strong even at 40 hr jected to immunoprecipitation with antibodies against
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the FLAG-tagged BPAG1 tail. As judged by SDS–
polyacrylamide gel electrophoresis and autoradiogra-
phy, a band of the expected size of NF-H selectively
associated with the 80 kDa BPAG1 tail and was coimmu-
noprecipitated with the antibody (Figure 5A). Immu-
noblot analysis of unlabeled COS cell extracts confirmed
that this z200 kDa band was indeed NF-H. The stoichi-
ometry of the association was z1:1, when size and
methionine content were considered and when the ra-
dioactivity in the bands was quantitated. When ex-
pressed by itself, NF-H remained in the soluble fraction
of detergent-containing cell extracts immunoprecipi-
tated with anti-BPAG1n. However, following cotransfec-
tion, BPAG1 antibody immunoprecipitated NF-H nearly
as efficiently as the NF-H antibody, confirming the asso-
ciation between the two proteins.
The Amino-Terminal Domain of BPAG1n Binds
Actin Filaments In Vivo and In Vitro
The location of anti-BPAG1n labeling within the axon,
coupled with the presence of a putative ABD in the
amino-terminal portion of BPAG1n, suggested that
BPAG1n might be tethered to the cytoskeleton of actin
MFs known to be present in the axon (Hirokawa, 1982;
Fath and Lasek, 1988). To assess whether this domain
has the capacity to associate with the actin cytoskele-
ton, we used DNA transfection to express the amino-
terminal portion of BPAG1n1 in SW13 cells. As shown in
Figures 4H–4J, antibodies against BPAG1n and b-actin
colocalized along the actin stress fibers and at the corti-
cal actin cytoskeleton underlying the plasma membrane
of these cells. Greater than 80% of the transfected cells
displayed this phenotype. This portion of BPAG1n did
not localize with NFs in cotransfected cells (Figure 4K).
To explore further the specificity of theamino-terminal
domain of BPAG1n for actin filaments, polymerized actin
was combined with GST–BPAG1n fusion protein (100
Figure 5. The BPAG1 Tail Forms a Complex With NF-H, and the nM) encompassing this domain. As a control, we used
BPAG1 Head Binds to Actin MFs a recombinant chicken tensin–GST fusion protein, con-
(A) COS cells were transfected with either pFG-BPAG1tail (lane 1),
MSV-NFL (lane 2), a 1:1 molar mixture of MSV-NFL and MSV-NFH
(lane 3), or pBPAG1n (lane 4). We lysed cells 36 hr after transfection
and resolved total proteins by electrophoresis through 10% or 6% (B) Actin binding assays. Binding assays were conducted as de-
SDS–polyacrylamide gels. Following transfer to nitrocellulose, blots scribed by Lo et al. (1994) to test the following: the ABD II of chicken
were first stained with Ponceau red to verify equal loading of protein tensin fused to GST (tensin; purified from p23-expressing cells; Lo
(data not shown) and then subjected to immunoblot analysis with et al., 1994); the ABD sequence of human brain BPAG1n fused to
anti-FLAG (lane 1), anti-NF-L (lane 2), anti-NF-H (lane 3), or anti- GST (BPAG/ABD); bovine serum albumin control (BSA); and GST
BPAG1n (lane 4). After washing, the blots were developed using protein control (data not shown). In brief, proteins (80 mg/ml) in P
enhanced chemiluminescence. Note the presence of a single band buffer (10 mM imidazone [pH 7.0], 75 mM KCl, 0.2 mM EGTA, 0.01%
of the expected size for each of the cell extracts. COS cells were also NP-40) were subjected to precentrifugation in a Beckman Airfuge
radiolabeled with 10 mCi/ml [35S]methionine (1 Ci/mmol; Amersham) to remove any aggregates and then combined with purified rabbit
following transfection with a 1:1 molar ratio of pFG-BPAG1tail and skeletal muscle F-actin (300 mg/ml in 0.2 mM ATP). After incubation
MSV-NFH (lane 5), MSV-NFH (lane 6), or pFG-BPAG1tail (lane 7). (1 hr at roomtemperature), samples were subjectedto centrifugation
After 28 hr, cells were processed for immunoprecipitation with anti- (100,000 3 g for 40 min) to pellet the F-actin and its associated
FLAG antibody in 20 mM Tris–HCl (pH 7.5), 1% Triton X-100, 0.1% proteins. Fractions were then separated by electrophoresis through
SDS, 5 mM EDTA. Following electrophoresis, the gel was subjected 8.5% SDS–polyacrylamide gels, which were then stained with Coo-
to autoradiography and exposed to X-ray film for 17 hr. Note that massie blue to visualize protein. The amounts of protein in thesuper-
in the presence of BPAG1 tail, NF-H is selectively immunoprecipi- natant (S) or actin-containing pellet (P) were determined by densito-
tated by anti-FLAG; vimentin (57 kDa), which also associates with metric scanning. Each assay was performed with (1) and without
the BPAG1 tail, is outside the size range necessary to visualize NF-H (2) polymerized actin filaments.
and BPAG1 tail. Finally, unlabeled COS cells were transfected, and (C) Estimation of the Kd of actin binding. Actin filament binding
immunoprecipitations were conducted. Following electrophoresis, assays were carried out as in (B), except that BPAG1n fusion protein
proteins were transferred to nitrocellulose, and the blot was probed was used at 100 nM, 200 nM, 300 nM, and 400 nm. Scatchard
with anti-NF-H and processed. Transfections and antibodies used analysis was conducted on two data sets, which were averaged
for immunoprecipitations were as follows: lane 8, pFG-BPAG1tail, (values differed by less than 10%). Plot shown gives, on the vertical
anti-FLAG; lane 9, MSV-NFH, anti-FLAG; lane 10, MSV-NFH plus axis, BPAG1n bound/free BPAG1n mM21, and on the horizontal axis,
pFG-BPAG1tail, anti-FLAG; lane 11, MSV-NFH, anti-NF-H. bound BPAG1n/F-actin.
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Figure 6. The Full-Length BPAG1n Can Reorganize an NF Network to Colocalize with the Actin Network in SW13 Cells
SW13 cells were transfected with a 1:1:1 molar ratio of MSV-NFL, MSV-NFH, and pBPAG1n1. Transfected cells were subjected to triple
immunofluorescence in (A)–(C) with anti-NF-H (1:300, rabbit polyclonal), m5e (BPAG1; 1:50, human monoclonal), and anti-bactin (1:100, mouse
monoclonal), respectively; in (D)–(F), anti-bactin, m5e (BPAG1), andanti-tubulin (1:100, rabbit polyclonal against tyrosinylated form), respectively.
Appropriate FITC-, Texas red–, or Fluoroblue-conjugated secondary antibodies wereused to detect boundantibodies. Shown are representative
cells from each immunofluorescence staining. Bar in (A) represents 12 mm for all frames.
taining a bona fide ABD (Lo et al., 1994). In the absence labeled with antibodies against NF-H (Figure 6A). How-
ever, in contrast with what we had observed in cotrans-of polymerized actin, neither ABD pelleted by centrifuga-
fections with the BPAG1 tail domain, this NF networktion at 100,000 3 g (Figure 5B). In contrast, addition of
coaligned with the actin stress fiber network (Figure 6C).polymerized actin resulted in a major portion of the ABD
This association between the two cytoskeletal networksnow pelleting with actin. That these associations were
involved BPAG1n (Figure 6B). The actin network, an-specific to ABD-containing proteins was underscored
chored to the cortical cytoskeleton and to focal con-by the failure of serum albumin or GST alone to shift to
tacts, appeared less affected than the NFs, which arethe pelletable fraction in this assay (see also Lo et al.,
free in the cytoplasm of SW13 cells transfected with1994, and references therein). Note that some actin did
NF-L and NF-H alone. Approximately 20% of triplenot pellet, but the relative percentage of actin that re-
transfected cells showed complete colocalization of allmained in solution was constant irrespective of whether
three antibodies, 50% showed partial colocalization,an ABD was added to the polymerized preparation. This
and z30% of the cells overexpressed one or more ofpresumably was reflective of unpolymerized actin.
the transgene proteins and therefore could not be cate-To estimate the binding constant of this association,
gorized. Only a small percentage (<5%) of cells express-we repeated these experiments, this time using a range
ing BPAG1n displayed distinct actin and NF networks.of BPAG1n concentrations from 100 nm to 400 nm. As
The association of the actin and NF networks in SW13expected, as the concentration of BPAG1n increased,
cells expressing BPAG1n did not appreciably affect thethe association of BPAG1n with polymerized actin be-
microtubule cytoskeleton. As shown in Figures 6D–6F,came saturating, and the level of BPAG1n in the soluble
the cytoskeleton formed among actin,BPAG1n, and NFsfraction increased. A Scatchard plot of the data is shown
did not colocalize with the microtubule network. Thus,in Figure 5C. The Kd of BPAG1n binding to actin was
if there are associations between BPAG1n and microtu-2.1 3 1027 M, within the range of that observed for
bules, these associations were not detected under theb-spectrin and other proteins with ABDs (Lo et al.,1994).
conditions used here.
Full-Length BPAG1n Has the Remarkable Capacity Abnormalities in the Neurofilament Architecture
to Coalign Actin and NF Networks in BPAG1 Knockout Mice
In view of the ABD at one end of the coiled-coil rod In view of the reorganization of the NF network in SW13
segment of BPAG1n and an NF-binding domain at the cells cotransfected with BPAG1n, we reexamined the
other end, we examined the ability of these associations pathology of the BPAG1 knockout animals to assess
to take place simultaneously. In this case, we con- whether the NF network within sensory axons might be
structed a full-length cDNA for the 280 kDa BPAG1n altered when BPAG1n is missing. First, we used the
and expressed it by DNA transfection. By immunoblot mouse monoclonal antibody SMI 31, which detects
analysis, a band of the expected size was produced NF-H when it is multiphosphorylated within its lysine-
(Figure 5A, lane 4). When NF-L, NF-H, and BPAG1n were serine-proline repeats in the tail (Sternberger and Stern-
berger, 1983). This antibody reacts broadly with axons,cotransfected into SW13 cells, NFs were formed that
Cell
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Figure 7. Ultrastructure of BPAG1 Mutant Mice Reveals Signs of Nerve Fiber Degeneration in the Dorsal Column and Sensory Axons
BPAG1 (2/2) mice and control littermates at 12 days of age were perfused with a solution of 2% glutaraldehyde and 4% paraformaldehyde,
and tissues were embedded in Epon. Tissues were processed as previously described (Coulombe et al., 1991) and examined with a Jeol 100
CX electron microscope at 80 kv. Shown are cross sections of the dorsal column of the spinal cord of BPAG1 (2/2) (A) and control (B) mice
and the ventral column of the spinal cord of BPAG1 (2/2) mice (C). Shown also are axons (D; axonal swelling with lysosomal vesicles denoted
by arrowheads) and cell body (E; note high density of NFs) from (2/2) DRG. Abbreviations are as follows: Ax, axon; My, myelinated sheath;
asterisks, signs of degeneration; arrows, early degeneration; Od, oligodendrocyte. Varying stages of degeneration are evident within z40%
of the (2/2) axons of the dorsal column, but not within the ventral column. By 28 days (data not shown), >90% of the sensory neurons are
degenerated, and eventually signs of degeneration, presumably secondary, are seen within the ventral column. Bar represents in (A) 0.8 mm
in (A)–(C); 0.9 mm in (D); and 0.5 mm in (E).
but nerve cell bodies are unreactive. In contrast, many average of 56% 6 17% difference in NF density per
unit area of axon cytoplasm. The initial reduction in NFcell bodies of the BPAG1 (2/2) DRG were labeled (data
not shown). Similar aberrations have been described in density seemed most prominent in areas close to the
axonal membrane. Accompanied by a reduction andcertain degenerative disorders of motor neurons where
NFs accumulate in perikarya (Xu et al., 1993; Cote et disorganization of NFs in axons was an accumulation
of NFs in cell bodies (Figure 7E).al., 1993).
Electron microscopy was used to examine the NF
network in 12d BPAG1 (2/2) sensory axons in greater Discussion
detail. Approximately 30% of the axons in the dorsal
column of the spinal cord were degenerated (Figure 7A), A Novel Kind of Cytoskeletal Connector:
Linking Actin and IFsa number which would rise to >90% by 4–5 weeks of
age (Guo et al., 1995). In contrast, the ventral root, hous- Our biochemical and molecular analyses indicate that
both neuronal isoforms of BPAG1 have the capacity toing motor axons emerging from the (2/2) spinal cord,
was largely unaffected (Figure 7C). bind simultaneously to the actin and IF cytoskeletons.
An ABD, not present in BPAG1e, resides at the aminoInspectionalong the length of the DRG axons revealed
regional swellings filled with lysosomal vesicles and dis- end of the coiled-coil rod. Its binding to polymerized
actin is with an affinity comparable with, if not strongerorganized arrays of neurofilaments (Figure 7D). Both
myelinated and nonmyelinated fibers seemed to be af- than, that of the well-established actin binding activity
of tensin (Lo et al., 1994). At the carboxy end of the rodfected. Axonal degeneration was also accompanied by
a reduction of NFs. In the dorsal column, there was an is an IF-binding domain, present in both BPAG1e and
BPAG1n: An Essential Cytoskeletal Linker Protein
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BPAG1n. In keratinocytes, this domain associates with Tsukita et al., 1986). Additionally, Fath and Lasek (1988)
have found a lattice of shorter, but abundant actin MFsthe keratin cytoskeleton, and in sensory neurons it binds
to NFs. in the axoplasm of squid DRGs, suggesting that actin
MFs play a role in the dynamic architecture of the centralMost remarkable is the ability of full-length BPAG1n
to realign NFs in relation to the actin cytoskeleton in axon. It has been widely speculated that the axonal
network of actin interacts with microtubules to play atransfected SW13 cells. Thus, the binding of BPAG1n
to one cytoskeletal network does not preclude its ability role in vesicle transport (Griffith and Pollard, 1978; Nem-
hauser and Goldberg, 1985). It may be that in theto associate with the other. This differs from brain
b-spectrin, which in one report appeared to bind either BPAG1n null mice, NFs become disorganized, resulting
in perturbations in these connections.NFs or actin MFs through the ABD (Frappier et al., 1992).
Our demonstration that the ABD of BPAG1n associates It seems likely that severing the BPAG1n connection
between NFs and MFs affects axonal transport. It hasonly with actin filaments and not NFs further under-
scores this distinction. already been established that aberrations in motor neu-
ron NFs, similar to the ones we describe for BPAG1More relevant to BPAG1n is that antibodies against
plectin partially localize not only to IFs, but also to actin (2/2) sensory neuron NFs, negatively affect axonal
transport (Collard et al., 1995). In addition, we cannotstress fibers and focal contacts in cultured cells (Foisner
et al., 1991; Seifert et al., 1992). That plectin may cross- rule out the possibility that the actin cytoskeleton may
be perturbed in BPAG1 (2/2) mice. In this regard, itlink actin and IF networks has recently been proposed
by Foisner et al. (1995), who showed by immunoelectron is interesting that biochemical disruption of MFs also
blocks axonal transport (Nemhauser and Goldberg,microscopy that antibodies against plectin label cross-
bridge-like structures that connect IFs with actin MFs 1985, and references therein).
It is interesting that the axon termini of certain sensoryin cytoskeletal extracts from glioma cells expressing
endogenous plectin. While this observation is intriguing, neurons contain BPAG1n. That BPAG1n function is im-
portant in these regions is underscoredby thedegenera-the partial colocalization by immunofluorescence, cou-
pled with the potential for artifacts in in vitro cytoskeletal tion of muscle spindles and nerve endings in the skin of
BPAG1 (2/2) mice (Guo et al., 1995; Sotelo and Guenet,preparations, has made it difficult to assess whether
these cross-bridges exist in vivo, whether they perform 1988). Although terminal boutons of parasympathetic
and motor axons have few if any NFs (Lasek and Hoff-a functional role, and whether the interaction, if real,
involves direct bridging by a single molecule. The role of man, 1976), the sensory axon termini at muscle spindles
and in skin may be more similar to the extensivelythis association has been further complicatedby studies
suggesting that plectin also associates with microtu- branched preterminal regions of parasympathetic ax-
ons, which are rich in NFs (Paggi and Lasek, 1987).bules and with b-spectrin (Foisner et al., 1991, 1995).
While the role of plectin in the cytoskeleton awaits Finally, it is intriguing that muscle spindles depend upon
their sensory nerves (and not their motor nerves) forthe generation of plectin null cells or animals, plectin
may perform a similar function to BPAG1n. We note here development and survival during the first 2 weeks after
birth (Zelena and Soukup, 1974), providing a partial ex-that this seems even more likely given that plectin shares
homology between amino acid residues 175–425 and planation as to why motor dysfunction occurs in the
BPAG1 knockout mice. To what extent BPAG1n maythe ABDs of BPAG1n and b-spectrin. In contrast to plec-
tin, however, BPAG1n does not seem to associate ap- perform multifaceted functions in the axons and axon
termini will need to be explored in more detail in thepreciably with microtubules, at least in the culture stud-
ies describedin this report. Whether BPAG1n associates future.
with other proteins, as plectin seems to do, remains to
be elucidated.
Why Would Disrupting the Linkage between ActinThe BPAG1 knockout provides direct genetic evi-
and NF Selectively Kill Sensory Neurons?dence that BPAG1n performs an essential function in
If BPAG1n provides a linkage between MFs and NFs,sensory neurons. Our immunohistochemistry and in situ
when are these linkages formed and are they more im-hybridizations reveal that BPAG1n is predominantly in
portant to sensory neurons than to other neurons? Theaxons and axon termini and not in the cell bodies of
BPAG1 (2/2) phenotype indicates that the attachmentsensory neurons. Further, the perturbation seen by elec-
is most needed following stable synapse formation intron microscopy in the axonal cytoskeleton of BPAG1
postnatal axons and preterminal axon branches.(2/2) mice strongly implies that BPAG1n performs an
Whether the attachment is inhibitory to migrating neu-actin–NF linkage in vivo and provides a graphic illustra-
rons, either developmentally or in response to injury,tion of the vital features of this novel type of cytoskeletal
will be of interest to address in the future, as is the issueconnector protein.
of how BPAG1n is prevented from associating with the
actin cytoskeleton in DRG perikarya where it is first syn-
thesized.What Is the Function of a Molecule That
Can Link Actin to NFs? It is perplexing that BPAG1n is not comparably ex-
pressed in motor neurons. Sensory neurons can varyBPAG1n now provides a molecular mechanism by which
the NF network can be tethered not only to the cortical dramatically in size, myelination, and axonal transport
rates, and hence any of these properties alone is unlikelycytoskeleton, but also to the axoplasmic actin cytoskel-
eton. Actin antibodies have revealed an array of MFs to account for this difference. Perhaps BPAG1n is a
member of a larger family of actin–IF linker moleculesthat underlie the axonal membrane (Hirokawa, 1982;
Cell
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